LAX.SH
DIAMINES & CHEMICALS LTD·CHEMICALS 57.95·Chemicals & Petrochemicals Companies
Price
241.81
+3.7%52W Range
Market Cap
₹243.15 Cr
Traded: ₹0.10 Cr (0.04%) 0.0x
Free Float: ₹87.39 Cr (0.11% of FF traded)
Volume · 60D trend
4.15 K 0.0x
Delivery: % 0.0x
View Delivery Data
Returns
RS Score
Create a free account to unlock your edge
Scanners, market pulse, FII/DII data, and TradingView charts — free forever
Valuation
Business Strength
Growth (3Y CAGR)
Balance Sheet
Cash Position
Others
MTF Exposure Trend
60 sessions · funded amount, % of FF, daily delta
LAX.SH
Growth Trends
| Metric | 10Y | 5Y | 3Y | 1Y | TTM | Trend |
|---|---|---|---|---|---|---|
| Sales | +1.0% | -9.0% | -30.0% | -- | -39.0% | Decelerating |
| ROE | -- | +10.0% | +1.0% | -- | -- | Decelerating |
| Return | +21.0% | -4.0% | -21.0% | -34.0% | -- | Decelerating |
| Profit | -- | -- | -- | -- | -707.0% | -- |
Quarterly Results
Mar 2023
Dec 2022
Sep 2022
Revenue & Margin Trends
Annual
Quarterly
Balance Sheet Health
Leverage
Efficiency
Cash Position
Detailed Financials
Jun 2026PDF ↗ | Mar 2026PDF ↗ | Dec 2025PDF ↗ | Sep 2025PDF ↗ | Jun 2025PDF ↗ | Mar 2025PDF ↗ | Dec 2024PDF ↗ | Sep 2024PDF ↗ | Jun 2024PDF ↗ | Mar 2024PDF ↗ | Dec 2023PDF ↗ | Sep 2023PDF ↗ | Jun 2023PDF ↗ | Mar 2023 | Dec 2022 | Sep 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 14 | 9 | 8 | 9 | 12 | 18 | 18 | 19 | 17 | 29 | 23 | 20 | 32 | 36 | 25 | 27 |
| Expenses | 14 | 12 | 11 | 13 | 16 | 16 | 16 | 16 | 18 | 26 | 18 | 15 | 22 | 23 | 13 | 11 |
| Operating Profit | 0 | -3 | -3 | -4 | -4 | 2 | 2 | 4 | -1 | 3 | 5 | 5 | 10 | 12 | 12 | 16 |
| Other Income | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 |
| Profit Before Tax | -0 | -3 | -3 | -4 | -3 | 2 | 1 | 3 | -2 | 3 | 4 | 5 | 10 | 13 | 12 | 17 |
| Tax % | 0.0% | -25.9% | -3.2% | -5.6% | -7.4% | 20.5% | 34.7% | 27.3% | 6.9% | 33.4% | 30.5% | 23.6% | 28.2% | 25.3% | 26.5% | 25.3% |
| Net Profit | -0 | -2 | -3 | -4 | -3 | 1 | 1 | 2 | -2 | 2 | 3 | 3 | 7 | 10 | 9 | 12 |
| Exceptional Items | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| EPS (Rs) | -0.1 | -2.4 | -3.5 | -4.2 | -2.9 | 1.3 | 0.8 | 2.5 | -1.8 | 2.3 | 2.9 | 3.5 | 7.2 | 9.8 | 9.1 | 12.6 |
| Sales Growth (YoY) | 17.3% | -48.2% | -56.4% | -51.5% | -27.3% | -39.0% | -24.0% | -3.7% | -46.9% | -17.7% | -7.4% | -26.2% | -- | -- | -- | -- |
| Sales Growth (QoQ) | 54.7% | 21.6% | -17.9% | -24.1% | -31.7% | 2.4% | -8.8% | 13.9% | -42.7% | 27.6% | 15.6% | -37.2% | -11.2% | 43.5% | -7.8% | -- |
| OP Growth (YoY) | 109.6% | -284.0% | -288.2% | -207.8% | -190.4% | -50.0% | -67.8% | -27.7% | -114.2% | -72.7% | -61.1% | -69.5% | -- | -- | -- | -- |
| OP Growth (QoQ) | 112.2% | -8.7% | 26.5% | 1.5% | -333.7% | 11.2% | -57.9% | 365.4% | -140.2% | -28.4% | -5.4% | -48.0% | -22.5% | 2.1% | -26.0% | -- |
| Profit Growth (YoY) | 96.0% | -292.0% | -553.0% | -269.0% | -61.0% | -44.0% | -73.0% | -28.0% | -125.0% | -76.0% | -69.0% | -72.0% | -36.0% | 34.0% | 260.0% | 268.0% |
| EPS Growth (YoY) | 96.5% | -286.8% | -552.0% | -268.9% | -60.3% | -43.9% | -73.1% | -28.1% | -125.0% | -76.5% | -68.7% | -72.4% | -- | -- | -- | -- |
| EPS Growth (QoQ) | 95.8% | 30.8% | 17.9% | -47.7% | -322.5% | 67.5% | -69.3% | 240.2% | -177.8% | -19.6% | -18.1% | -51.3% | -26.7% | 7.1% | -27.8% | -- |
| OP Margin | 2.6% | -33.5% | -37.4% | -41.8% | -32.2% | 9.4% | 8.7% | 18.8% | -8.1% | 11.5% | 20.5% | 25.1% | 30.3% | 34.7% | 48.7% | 60.7% |
| Net Margin | -0.7% | -26.1% | -44.5% | -44.6% | -22.9% | 7.0% | 4.3% | 12.8% | -10.4% | 7.7% | 12.2% | 17.1% | 22.1% | 26.8% | 35.9% | 45.9% |
| Material Cost % | -- | 74.0% | 53.0% | 57.0% | 46.0% | 40.0% | 52.0% | 44.0% | 68.0% | 58.0% | 44.0% | 38.0% | 43.0% | 42.0% | 25.0% | 16.0% |
| Employee Cost % | -- | 25.0% | 36.0% | 30.0% | 21.0% | 13.0% | 14.0% | 14.0% | 15.0% | 10.0% | 15.0% | 15.0% | 9.0% | 6.0% | 10.0% | 9.0% |
| P/S | 5.99 | 6.27 | 5.72 | 4.13 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| P/E | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| P/B | 1.55 | 1.54 | 1.75 | 1.53 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Exchange Filings
50Diamines & Chemicals Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/10/2026 ,inter alia, to consider and approve the Un-audited Financial ....
We submit herewith disclosure of Consent to Establish received for DACL Fine Chem Limited, Wholly Owned Subsidiary of the Company.
We herewith submit copies of notice published in newspapers regarding opening of special window for transfer and dematerialisation of physical shares.
We submit herewith certificate under Reg 74(5) of SEBI (DP) Regulations, 2018
We submit herewith disclosure of closure of Trading Window w.e.f. October 01, 2026.
We submit herewith scrutinizer''s report received for the AGM held on September 16, 2026
We submit herewith outcome of AGM held on September 16, 2026.
We submit herewith disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015.
Update on submission dated August 05, 2026 - Disclosure for Allotment of shares under DACL - ESOP 2021
We submit herewith letter containing the exact weblink and path of accessing the Annual Report for FY 2025-26 sent to shareholders.
We herewith submit copies of Notices published newspapers.
Annual Report FY 2025-26
Notice of Annual General Meeting - September 16, 2026
we herewith submit copies of notice published in newspapers regarding opening of special window for transfer and dematerialisation of physical shares.
Shareholder Meeting - Annual General Meeting on September 16, 2026
We submit herewith Unaudited Financial Results for the Quarter ended June 30,2026
Outcome of Board Meeting
Diamines & Chemicals Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/08/2026 ,inter alia, to consider and approve the Un-audited Financial ....
We submit herewith certificate under Reg 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended on June 30, 2026.
We wish to inform you that DACL Fine Chem Limited, Wholly Owned Subsidiary of the Company has signed binding term Sheet on June 29, 2026 with Kakinada SEZ Limited to purchase freehold ....
Intimation of Closure of Trading Window w.e.f. July 01, 2026
We submit herewith copies of notice published in newspapers regarding opening of special window for transfer and dematerialisarion of physical shares.
We herewith submit intimation received from RTA of the company regarding letter sent to shareholders for second 100 Days Campaign - "Saksham Niveshak".
We submit herewith Trading approval received for 2,69,402 equity shares of Rs. 10/- each allotted pursuant to conversion of warrants issued on Preferential basis from NSE & BSE.
We submit herewith copies of Notice published in Newspapers regarding transfer of shares of the Company to the Investor Education and Protection Fund.
We submit herewith Annual Secretarial Compliance Report for the FY 2025-26.
We submit herewith copy of notices sent to the shareholders, who have not claimed or encashed their dividend for seven or more consequent years.
We submit herewith Audited Financial Results for the quarter and year ended March 31,2026
Outcome of Board Meeting
We submit herewith statement of Deviation & variation under Reg 32 of SEBI LODR, 2015
Diamines & Chemicals Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 18/05/2026 ,inter alia, to consider and approve the Audited Financial ....
We submit herewith copies of notices published in newspapers regarding Special window for Re-lodgement of transfer requests of Physical shares and IEPF- second 100 days campaign- saksham Niveshak.
We submit herewith certificate under Ref 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended on March 31, 2026.
We submit herewith disclosure under Reg 30 of SEBI (LODR) Regulations regarding non-exercise of option to convert warrants.
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Amit M Mehta & Others
We submit herewith Disclosure dated March 25, 2026 under Regulation 29(2) of SEBI (Substantial Acquisition of shares and Takeovers) Regulations, 2011 received.
Intimation of Closure of Trading Window w.e.f. April 01, 2026
Outcome of Board Meeting dt 24.03.2026
Diamines & Chemicals Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/03/2026 ,inter alia, to consider and approve conversion of warrants ....
We submit herewith copies of notice published in Newspapers regarding intimation to shareholder for opening of special window for transfer and dematerialisation of Physical shares.
Disclosure of Regulation 32(1) of the SEBI (LODR) Regulations, 2015 for the Quarter ended on December 31, 2025
We submit herewith unaudited Financial Results for the quarter and nine months ended on 31.12.2025
Outcome of the Board Meeting
Diamines & Chemicals Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2026 ,inter alia, to consider and approve Unaudited Financial Results ....
We submit herewith announcement under Regulation 30 regrading CCA received from Gujarat Pollution Control Board.
We submit herewith certificate under Regulation 74 (5) of SEBI (DP) Regulations, 2018 for the quarter ended December 31, 2025, received from RTA.
Intimation of closure of Trading Window w.e.f. January 01, 2026.
We herewith submit copies of notice published in Newspapers regarding intimation to shareholder for opening of special window for re-lodgement of transfer request of physical shares.
We submit herewith unaudited Financial Results for the quarter and half year ended 30.09.2025
Outcome of Board Meeting
Annual Reports
15